RvD1 disrupts nociceptor neuron and macrophage activation and neuroimmune communication- reducing pain and inflammation in gouty arthritis in mice

Authors
TH Zaninelli, V Fattori, T Saraiva‐SantoS


Lab
Universidade Estadual de Londrina, Londrina, ParanA, Brazil

Journal
British Journal of Pharmacology

Abstract
Gouty arthritis is characterized by an intense inflammatory response to monosodium urate crystals (MSU), which induces severe pain. Current therapies are often ineffective in reducing gout-related pain. Resolvin D1 (RvD1) is a specialized pro-resolving lipid mediator with anti-inflammatory and analgesic proprieties. In this study, we evaluated the effects and mechanisms of action of RvD1 in an experimental mouse model of gouty arthritis, an aim that was not pursued previously in the literature.

BIOSEB Instruments Used:
Electronic Von Frey 4 (BIO-EVF4),Electronic Von Frey 5 with embedded camera (BIO-EVF5)

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.